Carl Torbjörn Bäckström
Fortune : 284 $ au 31/05/2026
Fortune : 284 $ au 31/05/2026
Carl Torbjörn Bäckström is the founder of Umecrine AB, founded in 2000, where the title held is Chief Executive Officer & Director.
Dr. Bäckström was the founder of Asarina Pharma AB, founded in 2006, where the title held was Chief Science Officer.
Dr. Bäckström was the founder of Umecrine Cognition AB, founded in 2006, where the titles held were Chief Science Officer & Director.
Dr. Bäckström currently holds the position of Independent Director at Diamyd Medical AB since 2017.
Dr. Bäckström currently holds the position of Senior Professor at Umea Universitet.
Dr. Bäckström currently holds the position of Professor at Obstetrics & Gynecology, Inc. Dr. Bäckström currently holds the position of Principal at Umeå Neurosteroid Research.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/08/2025 | 2 342 ( 0% ) | 284 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| DIAMYD MEDICAL AB | Directeur/Membre du Conseil | 01/04/2017 |
Umecrine AB
Umecrine AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pharmaceutical company that develops novel class of drugs to treat neurological disorders | Fondateur | 01/01/2000 |
Obstetrics & Gynecology, Inc.
Obstetrics & Gynecology, Inc. Medical/Nursing ServicesHealth Services Provides obstetrics and gynaecology & women's health services | Corporate Officer/Principal | 02/06/2010 |
Umea Universitet
Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 02/06/2010 |
Umeå Neurosteroid Research | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ASARINA PHARMA AB | Fondateur | - |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Umea Universitet
Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Umecrine AB
Umecrine AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pharmaceutical company that develops novel class of drugs to treat neurological disorders | Commercial Services |
Obstetrics & Gynecology, Inc.
Obstetrics & Gynecology, Inc. Medical/Nursing ServicesHealth Services Provides obstetrics and gynaecology & women's health services | Health Services |
Asarina Pharma AB
Asarina Pharma AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Health Technology |
Diamyd Medical AB
Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes | Health Technology |
Umeå Neurosteroid Research |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national